GSK Turkey organized a Health Systems Workshop


Representatives of important institutions in Turkey in the field of health and technology were hosted at the Health Systems Workshop organized with the participation of Prof. Dr. Rıfat Atun, Director of Global Health Systems Cluster at Harvard University at GSK Turkey

Innovative approaches and digital health solutions for better health outcomes were discussed in the workshop, which focused on COPD and asthma diseases. While evaluating the performance of the health system in Turkey during the workshop, the increasing burden of post-pandemic COPD and asthma on individuals and health economics was also addressed. During the two-day workshop, it was concluded that artificial intelligence and digital solutions could be used more effectively in these areas as a result of the exchange of ideas on the health solutions of the future.

In the evaluations made within the scope of the workshop, it was emphasized that Turkey is not at the desired level among other OECD countries in terms of the performance of the health system; Starting from asthma and COPD, it was discussed how to achieve better health outcomes in all chronic diseases.

Participating as the guest of honor at the workshop hosted by GSK Turkey, Prof. Dr. Rıfat Atun, Professor of Global Health Systems at Harvard University and Director of Global Health Systems Cluster at Harvard University at GSK Turkey moderated the panel and keynote presentation that took place throughout the event. In the panel on the digital ecosystem in health moderated by Atun, Evren Bükülmez, Technology Development Foundation of Turkey – Consultant to Secretary General, Selin Arslanhan, Founder & Managing Director at ReDis Innovation, Recai Serdar Gemici – Co-Founder & CEO at Albert Health, Ali Üstün, Partner at McKinsey & Company – Public Sector, Healthcare and Life Sciences / Digital & Analytics, Jülide Karagöz, Jülide Güzin Karagöz, Turkey Artificial Intelligence Initiative Strategist took part as a panelist. In addition, Zehra Çataltepe, the founder of Tazi, who participated in the workshop as a keynote speaker, discussed global trends in digital health and patient-oriented solutions for chronic disease management.

Stating that he was very happy to be invited to the workshop, Prof. Dr. Rıfat Atun said, “Asthma and COPD, which bring a great economic burden, rank third among all diseases in Turkey in terms of disease burden and mortality. The workshop and panel I directed for two days were both very valuable in terms of developing transformational solutions for better health outcomes in these two diseases, which are of great importance for public health in Turkey, and improving the health system in the country. Thanks again to everyone who contributed to this workshop.”

Selim Giray, General Manager at GSK Turkey also stated that they will be able to support the entrepreneurs leaving Turkey in the field of health in the future periods of this journey they started with an innovative stance and said, “As GSK Turkey, it is our top priority to benefit public health by bringing together all relevant stakeholders in the treatment areas in which we operate and developing innovative solutions. . Events like these, which we organize in this direction, are very valuable in terms of identifying problems, suggesting transformational solutions, establishing coalitions, and planning actions that will bring change with a holistic approach. Our very esteemed scientist Prof. Dr. I would like to thank Rıfat Atun for his valuable participation and moderation of our panels. I hope that our workshop will lead to important collaborations on behalf of the Turkish healthcare industry, and I would like to say that as GSK Turkey, we are always ready to support our entrepreneurs in this field.”